112 related articles for article (PubMed ID: 2564410)
21. Qualitative difference of subcellular localization of tumor-associated carbohydrate (Le(x)) antigens in renal cell carcinoma and normal kidney.
Ohtani H; Fukushi Y; Orikasa S; Nagura H
J Histochem Cytochem; 1991 Apr; 39(4):479-84. PubMed ID: 1672317
[TBL] [Abstract][Full Text] [Related]
22. [The clinical evaluation of sialyl Lewis Xi antigen in patients with gynecologic tumors].
Shimizu C; Inoue M; Sasagawa T; Shimizu H; Ueda G; Tanizawa O
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1393-8. PubMed ID: 2572654
[TBL] [Abstract][Full Text] [Related]
23. [Sialyl Lewis(x)-I (SLX) as a tumor-associated carbohydrate antigen in sera in patients with gastric and colorectal cancer--evaluation according to clinico-pathological factors].
Nakagoe T; Ishikawa H; Nakao H; Satoh T; Miyashita K; Yokota M; Takahira R; Kusano H; Shimizu T; Fukuda Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):819-25. PubMed ID: 2565704
[TBL] [Abstract][Full Text] [Related]
24. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1992 Jan; 10(1):95-101. PubMed ID: 1727929
[TBL] [Abstract][Full Text] [Related]
25. Serological and immunohistochemical studies on sialylated carbohydrate antigens in colorectal carcinoma.
Nakagoe T; Kusano H; Hirota M; Fukushima K; Hiratani K; Hara K; Tomita M
Gastroenterol Jpn; 1991 Jun; 26(3):303-11. PubMed ID: 1716232
[TBL] [Abstract][Full Text] [Related]
26. Expression of carbohydrate antigens in human pulmonary adenocarcinoma.
Kawai T; Suzuki M; Kase K; Ozeki Y
Cancer; 1993 Sep; 72(5):1581-7. PubMed ID: 8394200
[TBL] [Abstract][Full Text] [Related]
27. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
28. Expression of sialyl Lex, sialyl Lea, Lex and Ley glycotopes in secreted human ovarian cyst glycoproteins.
Yang Z; Wu JH; Kuo HW; Kannagi R; Wu AM
Biochimie; 2009 Mar; 91(3):423-33. PubMed ID: 19059303
[TBL] [Abstract][Full Text] [Related]
29. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens.
Zhang S; Zhang HS; Cordon-Cardo C; Reuter VE; Singhal AK; Lloyd KO; Livingston PO
Int J Cancer; 1997 Sep; 73(1):50-6. PubMed ID: 9334809
[TBL] [Abstract][Full Text] [Related]
30. [Clinical usefulness of tumor markers associated with pancreatic cancer].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
[TBL] [Abstract][Full Text] [Related]
31. Prediction of clinical course and recurrence of human ovarian cancer by several serum tumor markers.
Kikuchi Y; Kita T; Iwano I; Kuki E; Oomori K; Kizawa I
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):69-76. PubMed ID: 2926196
[TBL] [Abstract][Full Text] [Related]
32. Expression of SIALYL-Le(x) antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients.
Grabowski P; Mann B; Mansmann U; Lövin N; Foss HD; Berger G; Scherübl H; Riecken EO; Buhr HJ; Hanski C
Int J Cancer; 2000 Oct; 88(2):281-6. PubMed ID: 11004681
[TBL] [Abstract][Full Text] [Related]
33. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells.
Martín-Satué M; Marrugat R; Cancelas JA; Blanco J
Cancer Res; 1998 Apr; 58(7):1544-50. PubMed ID: 9537262
[TBL] [Abstract][Full Text] [Related]
34. [SLX (sialyl SSEA-1, sialyl Le(x)-i)].
Kannagi R; Izawa M; Koike T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():675-80. PubMed ID: 16149609
[No Abstract] [Full Text] [Related]
35. [A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
Ueoka H; Ohnoshi T; Moritaka T; Kiura K; Mima Y; Horiguchi T; Segawa Y; Tabata M; Shibayama T; Maeda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1022-8. PubMed ID: 1684395
[TBL] [Abstract][Full Text] [Related]
36. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
Paulick R; Kaesemann H; Caffier H
Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
[TBL] [Abstract][Full Text] [Related]
37. [Value of SLX and CA19-9 in the serum and tissue in colorectal cancer including the relation to Lewis blood type].
Igarashi K
Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2394-403. PubMed ID: 2574243
[TBL] [Abstract][Full Text] [Related]
38. [The accuracy of CT and tumor markers in the detection of a recurrent ovarian carcinoma].
Wakabayashi Y; Ishida J; Kotake F; Hirose M; Kawana K; Abe K; Amino S; Negishi Y; Akiya K
Gan No Rinsho; 1989 Sep; 35(10):1127-31. PubMed ID: 2550684
[TBL] [Abstract][Full Text] [Related]
39. Alpha1,2fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl Lewis X antigen generated within colorectal tumor tissues.
Tsuboi K; Asao T; Ide M; Hashimoto S; Noguchi K; Kominato Y; Saniabadi AR; Kuwano H; Yazawa S
Ann Surg Oncol; 2007 Jun; 14(6):1880-9. PubMed ID: 17375356
[TBL] [Abstract][Full Text] [Related]
40. Expression of Lewis(a), sialyl Lewis(a), Lewis(x) and sialyl Lewis(x) antigens as prognostic factors in patients with colorectal cancer.
Nakagoe T; Fukushima K; Nanashima A; Sawai T; Tsuji T; Jibiki M; Yamaguchi H; Yasutake T; Ayabe H; Matuo T; Tagawa Y; Arisawa K
Can J Gastroenterol; 2000 Oct; 14(9):753-60. PubMed ID: 11064310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]